3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
311
Neoplasm Metastasis
38
Neoplasms
22
Advanced Breast Cancer
19
Ovarian Neoplasms
18
Carcinoma, Non-Small-Cell Lung
14
Endometrial Neoplasms
11
Prostatic Neoplasms
10
Hereditary Sensory and Autonomic Neuropathies
10
Triple Negative Breast Neoplasms
8
Colorectal Neoplasms
6
Breast Cancer Metastatic
6
Uterine Cervical Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Recurrence
5
Carcinoma, Ovarian Epithelial
5
Neoplasms by Site
4
Multiple Endocrine Neoplasia Type 1
4
Breast Diseases
4
Stomach Neoplasms
3
Small Cell Lung Carcinoma
3
Lung Neoplasms
3
Head and Neck Neoplasms
3
Fallopian Tube Neoplasms
3
Carcinoma, Lobular
3
Uterine Neoplasms
2
Pancreatic Neoplasms
2
Melanoma
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Interventions
Octreotide
6
Irinotecan
6
Loperamide
5
Probiotics
3
Leucovorin
3
Fluorouracil
3
Fecal Microbiota Transplantation
3
Calcium Aluminosilicate
3
maltodextrin
2
telotristat ethyl
1
shosaiko-to
1
lanreotide
1
isatuximab
1
ceterizine hydrochloride
1
capivasertib
1
cabazitaxel
1
bile acid binding proteins
1
XRP6258
1
Theophylline
1
Temozolomide
1
Surveys and Questionnaires
1
Sulfasalazine
1
Sugars
1
Standard of Care
1
Raloxifene Hydrochloride
1
Radiation
1
Prednisone
1
PHY 906
1
Oxaliplatin
1
Long-Term Synaptic Depression
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Diarrhea
×
Fulvestrant
×
Clear all
NCT07426822
2026-02-24
SAFE-CAP
Yale University
Phase 2
Not yet recruiting
108 enrolled